Early research (Phase 1)WithdrawnNCT02210104What this trial is testingAdoptive Therapy Using Antigen-Specific CD4 T-CellsWho this might be right forMelanomaSarcoma M.D. Anderson Cancer Center
Not applicableNo Longer AvailableNCT00547235What this trial is testingEmergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV InfectionWho this might be right forInfectionPrecancerous/Nonmalignant Condition Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00182650What this trial is testingCellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma City of Hope Medical Center 5
Early research (Phase 1)Not Yet RecruitingNCT07414979What this trial is testingPhase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal MelanomaWho this might be right forLeptomeningeal Melanoma M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)UnknownNCT02529579What this trial is testingSafety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic CancerWho this might be right forCarcinoma, Pancreatic Ductal Changhai Hospital 187
Testing effectiveness (Phase 2)Study completedNCT00385788What this trial is testingAllogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's DiseaseWho this might be right forHodgkin's Disease M.D. Anderson Cancer Center 52
Early research (Phase 1)Study completedNCT00045149What this trial is testingBiological Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03410368What this trial is testingNK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer.Who this might be right forSmall Cell Lung Cancer jiuwei cui 120
Early research (Phase 1)Study completedNCT03247309What this trial is testingTCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)Who this might be right forSolid TumorCancerRecurrent Solid Tumors+1 more Immatics US, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT01319565What this trial is testingProspective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...Who this might be right forMetastatic MelanomaSkin Cancer National Cancer Institute (NCI) 102
Testing effectiveness (Phase 2)UnknownNCT03497533What this trial is testingTreatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19Who this might be right forNon-hodgkin Lymphoma,B Cell Timmune Biotech Inc. 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02028455What this trial is testingA Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ LeukemiaWho this might be right forCD19+ Acute Leukemia Seattle Children's Hospital 167
Testing effectiveness (Phase 2)Looking for participantsNCT07500220What this trial is testingDual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCCWho this might be right forAdvanced Hepatocellular Carcinoma (HCC)Metastatic Liver Cancer Beijing Biotech 30
Early research (Phase 1)Study completedNCT00101257What this trial is testingCellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal Cavity Cancer Fred Hutchinson Cancer Center 18
Early research (Phase 1)Ended earlyNCT02706392What this trial is testingGenetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesWho this might be right forHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell Carcinoma+10 more Fred Hutchinson Cancer Center 21
Early research (Phase 1)Looking for participantsNCT07572136What this trial is testingAnti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)Who this might be right forB-AllAcute Lymphoblastic Leukemia National Cancer Institute (NCI) 57
Early research (Phase 1)WithdrawnNCT01336478What this trial is testingCD56+CD3- NK Cells Following Allogeneic Stem Cell TransplantationWho this might be right forHaematological MalignanciesAllogeneic Stem Cell TransplantCD56+CD3- NK Cells Imperial College London
Testing effectiveness (Phase 2)Looking for participantsNCT06045910What this trial is testingA Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell MalignanciesWho this might be right forLymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell+3 more Cancer Research UK 84
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01868490What this trial is testingThe Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK CellsWho this might be right forCholangiocarcinomaNeuroblastoma Siriraj Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00096382What this trial is testingCyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Institutes of Health Clinical Center (CC) 34